AAAAAA
Results:
1-13
|
Results: 13
Authors:
Xu, LF
Daly, T
Gao, CH
Flotte, TR
Song, SH
Byrne, BJ
Sands, MS
Ponder, KP
Citation: Lf. Xu et al., CMV-beta-actin promoter directs higher expression from an adeno-associatedviral vector in the liver than the cytomegalovirus or elongation factor 1 alpha promoter and results in therapeutic levels of human factor X in mice, HUM GENE TH, 12(5), 2001, pp. 563-573
Authors:
Stacpoole, PW
Fisher, WR
Flotte, TR
Geiser, EA
Theriaque, DW
Hutson, AD
Citation: Pw. Stacpoole et al., Teaching hypothesis-oriented thinking to medical students: The University of Florida's Clinical Investigation Program, ACAD MED, 76(3), 2001, pp. 287-292
Authors:
Song, S
Embury, J
Laipis, PJ
Berns, KI
Crawford, JM
Flotte, TR
Citation: S. Song et al., Stable therapeutic serum levels of human alpha-1 antitrypsin (AAT) after portal vein injection of recombinant adeno-associated virus (rAAV) vectors, GENE THER, 8(17), 2001, pp. 1299-1306
Authors:
Song, SH
Laipis, PJ
Berns, KI
Flotte, TR
Citation: Sh. Song et al., Effect of DNA-dependent protein kinase on the molecular fate of the rAAV2 genome in skeletal muscle, P NAS US, 98(7), 2001, pp. 4084-4088
Authors:
Goudy, K
Song, SH
Wasserfall, C
Zhang, YC
Kapturczak, M
Muir, A
Powers, M
Scott-Jorgensen, M
Campbell-Thompson, M
Crawford, JM
Ellis, TM
Flotte, TR
Atkinson, MA
Citation: K. Goudy et al., Adeno-associated virus vector-mediated IL-10 gene delivery prevents type 1diabetes in NOD mice, P NAS US, 98(24), 2001, pp. 13913-13918
Authors:
Flotte, TR
Laube, BL
Citation: Tr. Flotte et Bl. Laube, Gene therapy in cystic fibrosis, CHEST, 120(3), 2001, pp. 124S-131S
Authors:
Owen, R
Lewin, AP
Peel, A
Wang, JM
Guy, J
Hauswirth, WW
Stacpoole, PW
Flotte, TR
Citation: R. Owen et al., Recombinant adeno-associated virus vector-based gene transfer for defects in oxidative metabolism, HUM GENE TH, 11(15), 2000, pp. 2067-2078
Authors:
Virella-Lowell, I
Poirier, A
Chesnut, KA
Brantly, M
Flotte, TR
Citation: I. Virella-lowell et al., Inhibition of recombinant adeno-associated virus (rAAV) transduction by bronchial secretions from cystic fibrosis patients, GENE THER, 7(20), 2000, pp. 1783-1789
Authors:
Seo, BB
Wang, JM
Flotte, TR
Yagi, T
Matsuno-Yagi, A
Citation: Bb. Seo et al., Use of the NADH-quinone oxidoreductase (NDI1) gene of Saccharomyces cerevisiae as a possible cure for complex I defects in human cells, J BIOL CHEM, 275(48), 2000, pp. 37774-37778
Authors:
Afione, SA
Wang, JM
Walsh, S
Guggino, WB
Flotte, TR
Citation: Sa. Afione et al., Delayed expression of adeno-associated virus vector DNA, INTERVIROLO, 42(4), 1999, pp. 213-220
Authors:
Wagner, JA
Messner, AH
Moran, ML
Daifuku, R
Kouyama, K
Desch, JK
Manley, S
Norbash, AM
Conrad, CK
Friborg, S
Reynolds, T
Guggino, WB
Moss, RB
Carter, BJ
Wine, JJ
Flotte, TR
Gardner, P
Citation: Ja. Wagner et al., Safety and biological efficacy of an adeno-associated virus vector cystic fibrosis transmembrane regulator (AAV-CFTR) in the cystic fibrosis maxillary sinus, LARYNGOSCOP, 109(2), 1999, pp. 266-274
Authors:
Beck, SE
Jones, LA
Chesnut, K
Walsh, SM
Reynolds, TC
Carter, BJ
Askin, FB
Flotte, TR
Guggino, WB
Citation: Se. Beck et al., Repeated delivery of adeno-associated virus vectors to the rabbit airway, J VIROLOGY, 73(11), 1999, pp. 9446-9455
Authors:
Hernandez, YJ
Wang, JM
Kearns, WG
Loiler, S
Poirier, A
Flotte, TR
Citation: Yj. Hernandez et al., Latent adeno-associated virus infection elicits humoral but not cell-mediated immune responses in a nonhuman primate model, J VIROLOGY, 73(10), 1999, pp. 8549-8558
Risultati:
1-13
|